A-Mei Huang
@
Kaohsiung Medical University
Introduction
Members
Resources
Courses
Weblinks
Photos
KMU
club
QR
code
Main
Focus
My laboratory is mainly focusing on studying the molecular roles
of transcription factor CCAAT/enhancer binding protein delta (C/EBPdelta).
Research Projects
The main projects are
1) Molecular characterization of C/EBPdelta in maintaining genomic stability
in mouse embryonic fibroblasts (MEFs);
2) The role of C/EBPdelta in apoptosis and cell cycle regulation;
3) Molecular mechanisms of C/EBPdelta-mediated drug resistance in human
urothelial carcinoma cells.
4) Exploration of alternative therapeutic strategies for chemo-drug resistance
by identification of novel compounds with diverse biological activities.
Grants
1. The role
of C/EBPdelta in the maintenance of genomic integrity (2006/1~2006/7)
Grant ID：KMU-Q095018 (MKU)
Role：Principle investigator
2. Molecular mechanisms of C/EBPdelta in apoptosis of breast tumor
cells (2006/8~2007/7)
Grant ID：NSC 95-2320-B-037-048 (NSC)
Role：Principle investigator
3. The role of C/EBPdelta in cisplatin resistance (2006/12~2007/7)
Grant ID：KMU-Q096009 (KMU)
Role：Principle investigator
4. Molecular mechanisms of transcription factor Cebpd in maintenance
of genome integrity in mouse embryonic fibroblasts (2008/4/1~2008/12/31)
Grant ID：KMU-M097004 (KMU)
Role：Principle investigator
5. Identification of differential expression regulatory networks
associated with drug response in chemosensitive and chemoresistant breast
cancer(2009/8/1~2010/7/31)
Grant ID：NSC 98-2218-E-231-002- (NSC)
Role：Co-Principle investigator
6. Molecular mechanisms of CEBPD-mediated cisplatin resistance
in human urothelial carcinoma cells (2008/8~2011/7)
Grant ID：NSC 97-2320-B-037-018-MY3 (NSC)
Role：Principle investigator
7. Evaluating CEBPD-mediated pathways in human urothelial carcinoma
treatment: the molecular mechanisms in drug resistance (2011/8~2012/7)
Grant ID：NSC 100-2320-B-037-013- (NSC)
Role：Principle investigator
8. Identification of dysregulated pathways using stretched metastasis-induced
graph – A case study of prostate cancer (2012/8/1~2013/7/31)
Grant ID：NSC 101-2221-E-231-030- (NSC)
Role：Co-Principle investigator
9.CEBPD in the tumorigenesis of human urothelial carcinoma (2012/12/1~2013/12/31)
Grant ID：KMU-M102008 (KMU)
Role：Principle investigator
10 . PTEN in CEBPD-mediated cisplatin responsiveness and its applications
(2013/8/1~2014/7/31)
Grant ID：NSC 102-2320-B-037-026- (NSC)
Role：Principle investigator
11. CEBPD-mediated chemotherapeutic drug responsiveness and resistance
in urothelial carcinoma: focusing on cisplatin-AKT-CEBPD-PTEN axis (2014/8~2015/7)
Grant ID：103-2320-B-037 -029 - (Ministry of Science and Technology)
Role：Principle investigator
12. Applications
of cyclooxygenase inhibitors in urothelial carcinoma and cisplatin resistant
sublines and the mechanistic studies (2016/1/1~2016/12/31)
Grant
ID：KMU-M105002 (KMU)
Role：Principle investigator
13. Long - term surveillance and investigation of Aedes mosquitoes
in Kaohsiung City - Southern Kaohsiung Districts (2017/5/1~2017/12/31)
Grant
ID： NHRI-106A1-MRCO-1017174
Role：Principle investigator
14.Refining and continuing
long-term surveillance and investigation of Aedes mosquitoes in Southern
Kaohsiung Districts (2018/1/1~2018/12/31)
Grant
ID： NHRI-07A1-MRPP33-035
Role：Principle
investigator
15. CEBPD and its miRNA targets in urothelial carcinoma progression
and drug resistance development (2018/8/1~2019/07/31)
Grant
ID：MOST 107-2314-B-037-014 -
(Ministry of Science and Technology)
Role：Principle
investigator
16. Establish and optimize the molecular analyzing method for
detecting the dengue virus in Aedes mosquitoes (2019/1/1~2019/12/31)
Grant
ID： NHRI-MR-108-CO-10
Role：Principle
investigator
17.Molecular mechanism of CEBPD regulating microRNA miR-17-92
cluster in upper tract /urothelial carcinoma progression and drug resistance
development (2019/08/1~2022/07/31)
Grant
ID：MOST 108-2314-B-037-031-MY3
(Ministry of Science and Technology)
Role：Principle
investigator
18.
Exploration of the deubiquitinase USP2a targets in urothelial carcinoma
tumorigenesis and chemotherapeutic drug responses (2023/1/1~2023/12/31)
Grant
ID：KMU-M112020 (KMU)
Role：Principle investigator
Posters
(click)
Patents
1.專利名稱:
熊果酸衍生物及其醫護組合物
發明人: 林忠男、涂皇堯、黃阿梅、魏百祿、顏金鳳、侯自銓、楊世群、蒲永孝、翁舷誌
證書號碼: I386415 (中華民國)
2.專利名稱: 作用於微小管抗癌藥物2',5'-dimethoxychalcone衍生物之合成與活性評估
發明人: 林忠男、涂皇堯、黃阿梅、侯自銓、楊世群、蒲永孝、張建國
專利證書號碼: I419687 (中華民國)
3.專利名稱: 抗人類泌尿上皮癌之香桂超臨界萃取物、製備方法及用途
發明人: 李志恒、黃阿梅、陳中一、連培榮、劉瓊惠
專利證書號碼: I448295 (中華民國)
4.專利名稱:The anti-human urothelial
carcinoma of supercritical carbon dioxide extract of cinnamomum subavenium,
and the preparation process and uses
發明人: 李志恒、黃阿梅、陳中一、連培榮、劉瓊惠
(Jih-Heng Li, A-Mei Huang,
Chung-Yi Chen, Pei-Jung Lien, Chiung-Hui Liu)
專利證書號碼:US8,669,377B2
(美國)
5. 專利名稱: 熊果酸衍生物及其醫護組合物
發明人: 林忠男、涂皇堯、黃阿梅、魏百祿、顏金鳳、侯自銓、楊世群、蒲永孝、翁舷誌
證書號碼: US 8729055B2 (美國)
6.專利名稱: 18β-甘草次酸衍生物及其用途
發明人: 林忠男、林凱偉、黃阿梅、侯自銓、楊世群、蒲永孝、張建國
證書號碼: I424839 (中華民國)
7.專利名稱: Derivative of 18β-glycyrrhetinic
acid APT to suppress cancer cells
發明人: 林忠男、林凱偉、黃阿梅、侯自銓、楊世群、蒲永孝、張建國
證書號碼: US 8,686,178 B2
(美國)
Publications
No. |
Title | Journal | IF and ranking |
1 |
Huang, AM, Chang, TJ, Cho, WL, and Chou, CK. 1998. From mosquito to man: identification of a novel protein kinase, HsHPK, which is highly expressed in human hepatoma tissues.(pdf) | J. Biomed. Sci. 1998. 5(2): 135-140. (SCI) | IF: 2.013 |
2 |
Lee, HS, Huang, AM, Huang, GT, Yang, PM, Chen, PJ, Sheu, JC, Lai, MY, Lee, SC, Chou, CK, and Chen, DS. 1998. Hepatocyte growth factor stimulates the growth and activates mitogen-activated protein kinase in human hepatoma cells. (pdf) | J. Biomed. Sci. 1998. 5(3): 180-184. (SCI) | IF: 2.013 ranking: 45/82 (2008) |
3 |
Shen, HH, Huang, AM, Hoheisel, J, and Tsai, SF. 2001. Identification and characterization of a SET/NAP protein encoded by a brain-specific gene, MB20. (pdf) | Genomics. 2001. 71(1): 21-33. (SCI) | IF: 3.327 ranking: 37/152 (2009) |
4 |
Liu, MA, Huang, AM, Chou, CK, Liaw, GJ, and Wu, CW. 2001. Utilization of Drosophila eye to probe the functions of two mammalian Serine/Threonine kinases, Snk and HsHPK. (pdf) | J. Biomed. Sci. 2001. 8(3): 270-277. (SCI) | IF: 2.013 ranking: 45/82 (2008) |
5 |
Huang, AM, Montagna, C, Ni, Y, Sharan, S, Ried, T and Sterneck, E. 2004. Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability. (pdf) | Oncogene. 2004. 23(8): 1549-1557. (SCI) | IF:7.216 ranking: 13/141 |
6 |
Thangaraju M, Rudelius, M, Bierie, B, Raffeld, M, Sharan, S, Hennighausen, L, Huang, AM, and Sterneck, E. 2005. C/EBP delta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. (pdf) | Development. 2005. 132(21):4675-4685. (SCI) | IF:
6.812 ranking: 5/37 |
7 |
Huang, AM, Rudelius, M, Sharan, S, McAllister, JM, Raffeld, M, Christenson, LK, and Sterneck, E. 2007. The Cebpd (C/EBPdelta) gene is induced by luteinizing hormones in ovarian theca and interstitial cells but is not essential for mouse ovary function. (pdf) | PLoS ONE 2007. 2: e1334. (SCI) | IF: 4.351 ranking: 9/73 (2009) |
8 |
Lin, KW#, Huang, AM#, Tu, HY, Weng, JR, Hour, TC, Wei, BL, Yang, SC, Wang, JP, Pu, YS, and Lin, CN*. 2009. Phloroglucinols inhibit chemical mediators and xanthine oxidase, and protect cisplatin-induced cell death by reducing reactive oxygen species in normal human urothelial and bladder cancer cells. (pdf) | J Agric Food Chem
2009. 57: 8782-8787. (SCI) |
IF: 2.562 ranking: 2/35 (2008) |
9 |
Tu, HY#, Huang, AM#, Wei, BL, Gan, KH, Hour, TC, Yang, SC, Pu, YS, and Lin, CN*. 2009. Ursolic acid derivatives induce cell cycle arrest and apoptosis in NTUB1 cells associated with reactive oxygen species. (pdf) | Bioorg Med Chem 2009.
17: 7265-7274. (SCI) (#Co-first author) |
IF:
3.075 ranking: 10/40 (2008) |
10 |
Pu, YS, Huang, CY, Kuo, YZ, Kang, WY, Liu, GY, Huang, AM, Yu, HJ, Lai, MK, Huang, SP, Wu, WJ, Chiou, SJ, and Hour, TC*. 2009. Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma. (pdf) | J. Biomed. Sci. 2009. 16(1): 82-92. (SCI) | IF: 2.013 ranking: 45/82 (2008) |
11 |
Wang, YC, Tsai, YS, Huang, JL, Lee, KW, Kuo, CC, Wang, CS, Huang, AM, Chang, JG, Jong, YJ and Lin, CS*. 2010. Arecoline arrests cells at prometaphase by deregulating mitotic spindle assembly and activating spindle assembly checkpoint. (pdf) | Oral Oncology. 2010. 46(4):255-62. (SCI) | IF:
2.928 ranking: 5/55 (2009) |
12 |
Chen, HL, Lin, KW, Huang, AM, Tu, HY, Wei, BL, Hour, TC, Yen, MH, Pu, Y and Lin, CN*. 2010. Terpenoids induce cell cycle arrest and apoptosis from the stems of Celastrus kusanoi associated with reactive oxygen species. (pdf) | J Agric Food Chem 2010. 58(6):3808-12. (SCI) | IF:
2.469 ranking: 2/44 (2009) |
13 |
Tu HY, Huang AM, Hour TC, Yang SC, Pu YS, and Lin CN*. 2010. Synthesis and biological evaluation of 2',5'-dimethoxychalcone derivatives as microtubule-targeted anticancer agents. (pdf) | Bioorg Med Chem. 2010. 18 (6): 2089-2098. (SCI) | IF: 2.822 ranking: 17/57 (2009) |
14 |
Hour, TC, Lai, YL, Kuan, CI, Chou, CK, Wang, JM, Tu, HY, Hu, HT, Lin, CS, Wu, WJ, Pu, YS, Sterneck, E, and Huang, AM*. 2010. Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cells. (pdf) | Biochem. Pharmacol. 2010. 80(3):325-334. (SCI) (*corresponding author) | IF: 4.254 ranking: 34/237 (2009) |
15 |
Pawar, SA, Sarkar, TR, Balamurugan, K, Sharan, S, Wang, J, Zhang, Y, Dowdy, SY, Huang, AM, and Sterneck E*. 2010. C/EBPdelta targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. (pdf) | Proc Natl Acad Sci USA. 2010. 107(20):9210-5. (SCI) | IF: 9.432 ranking: 3/50 (2009) |
16 |
Huang, CY, Chen, JYF, Wu,JE, Pu, YS, Liu, GY, Pan, MH, Huang, YT, Huang, AM, Hwang, CC, Chung, SJ, and Hour, TC*. 2010. Ling-Zhi polysaccharides potentiates cytotoxic effects of anti-cancer drugs against drug-resistant urothelial carcinoma cell.(pdf) | J Agric Food Chem. 2010. 58(15):8798-805. (SCI) | IF:
2.469 ranking: 2/44 (2009) |
17 |
Wang J, Sarkar TR, Zhou M, Sharan S, Ritt DA, Veenstra TD, Morrison DK, Huang, AM, and Sterneck E*. 2010. C/EBPdelta-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage. (pdf) | Proc Natl Acad Sci USA. 2010. 107(37): 16131-6. (SCI) | IF:
9.432 ranking: 3/50 (2009) |
18 |
Lin CN#, Huang AM#, Lin KW#, Hour TC, Ko HH*, Yang SC, and Pu YS. 2010. Xanthine oxidase inhibitory terpenoids of Amentotaxus formosana protect cisplatin-induced cell death by reducing reactive oxygen species (ROS) in normal human urothelial and bladder cancer cells. (pdf) | Phytochemistry 2010.
71(17-18):2140-6. (SCI) (#Co-first author) |
IF: 3.104 ranking: 24/173 (2009) |
19 |
Pan YC, Li CF, Ko CY, Pan MH, Chen PJ, Tseng JT, Wu WC, Chang WC, Huang AM, Sterneck E, and Wang JM*. 2010. CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells. (pdf) | Clin Cancer Res. 2010. 16(23):5770-80. (SCI) | IF: 6.747 ranking: 16/166 (2009) |
20 |
Lin, KW#, Huang, AM#, Tu, HY, Lee, LY, Wu, Hour, TC, Yang, SC, Pu, YS and Lin, CN*. 2011. Xanthine Oxidase Inhibitory Triterpenoid and Phloroglucinol from Guttiferaceous Plants Inhibit Growth and Induced Apoptosis in Human NTUB1 Cells Through a ROS-Dependent Mechanism. (pdf) | J Agric Food Chem. 2011. 59(1):407-14. (SCI) (#Co-first author) | IF: 2.816 ranking: 2/55 (2010) |
21 |
Ko, CY, Chang, LH, Lee, YC, Sterneck, E, Cheng, CP, Chen, SH, Huang, AM, Tseng, JT, and Wang, JM*. 2010. CAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells. (pdf) | Neurobiology of Aging. 2012. 33(2): 422.e11-422.e25 (SCI) | IF: 6.634 ranking: 3/45 (2010) |
22 |
Cheng,JH#, Huang, AM#, Hour, TC, Yang, SC*, Pu, YS and Lin, CN*. 2011. Antioxidant xanthone derivatives induce cell cycle arrest and apoptosis and enhance cell death induced by cisplatin in NTUB1 cells associated with ROS. (pdf) | Eur J Med Chem. 2011. 46(4):1222-31. (SCI) (#Co-first author) | IF:3.193 ranking: 11/54 (2010) |
23 |
Chao,
SY, Chiang, JH*, Huang, AM*, and Chang, WS.
2011. An integrative approach to identifying cancer chemoresistance-associated
pathways. (pdf)
 |
BMC Med Genomics 2011. 4(1):23-37. (SCI) (*co-correspondence) | IF:3.766 ranking: 47/156 (2010) |
24 |
Huang, AM*,
Kao, YT, Toh, S, Lin, PY, Chou, CH, Hu, HT, Lu, CY, Liou, JY, Chao,
SY, Hour, TC and Pu, YS. 2011. UBE2M-mediated p27Kip1 degradation
in gemcitabine cytotoxicity. (pdf) |
Biochem. Pharmacol. 2011. 82(1):35-42. (SCI) (*corresponding author) | IF: 4.889 ranking: 20/249 (2010) |
25 |
Liu, CH, Chen, CY, Huang, AM* and Li, JH*. Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1. (pdf) | J Ethnopharmacology 2011 137(1): 503-511 (SCI) (*co-correspondence) |
IF:2.466 ranking: 37/187 (2010) |
26 |
Lin, KW, Huang, AM, Hour, TC, Yang, SC*, Pu, YS and Lin, CN*. 2011. 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells. (pdf) | Bioorg Med Chem 2011. 19(14):4274-85 |
IF:2.978 ranking: 15/54 (2010) |
27 |
Wu, SR, Li, CF, Hung,
LY, Huang, AM, Tseng, JT, Tsou, JH and Wang,
JM.* 2011. CCAAT/enhancer binding protein delta mediates TNFalpha-induced
aurora kinase C transcription and promotes genomic instability. (pdf) |
J. Biol. Chem. 2011. 286(33):28662-70 | IF: 5.328 ranking: 50/286 (2010) |
28 |
Tu, HY#, Huang, AM#, Teng, CH#, Hour, TC, Yang, SC*, Pu, YS and Lin, CN*. 2011. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells. (pdf) | Bioorg Med Chem. 2011. 19: 5670-5678 (#Co-first author) | IF:2.978 ranking: 15/54 (2010) |
29 |
Lin, KW, Huang, AM, Yang, SC*, Weng, JR, Hour, TC, Pu, YS, and Lin, CN*. Cytotoxic and antioxidant constituents from Garcinia subelliptica. (pdf) | Food Chemistry. 2012. 135 (2): 851-859 |
IF 3.655 |
30 |
Lin, KW, Lin, ZY, Huang, AM, Weng, JR, Yen, MH, Yang, SC*, Lin, CN*. Lantabetulic Acid Derivatives Induce G1 Arrest and Apoptosis in Human Prostate Cancer Cells. (pdf) | Archiv der Pharmazie. 2014. 347(1): 42-53 | IF: 1.54, ranking: 69/152 (2012) |
31 |
Kao, YT, Hsu, WC, Hu, HT, Hsu, SH, Lin, CS, Chiu, CC, Lu, CY, Hour, TC, Pu, YS and Huang, AM*. Involvement of p38 MAPK in acquired gemcitabine-resistant human urothelial carcinoma sublines. (pdf) | KAOHSIUNG J MED SCI. 2014. 30(7):323-330. | IF 0.502, ranking: 104/121 (2012) |
32 |
Hour, TC, Chung, SD, Kang, WY, Lin, YC, Chuang, SJ, Huang, AM, Wu, WJ, Huang, SP, Huang, CY, and Pu YS*. EGFR mediates docetaxel-resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1). (pdf) | Arch Toxicol. 2015. 89(4):591-605. | IF 5.215, ranking: 6/85 (2012)
|
33 |
Lin, KW, Huang, AM*, Lin, CC, Chang, CC, Hsu, WC, Hour, TC, Pu, YS , and Lin, CN*. Anti-cancer effects of ursane triterpenoid as a single agent and in combination with cisplatin in bladder cancer. (pdf) | EUROPEAN JOURNAL OF PHARMACOLOGY. 2014. 740:742-51 (*co-correspondence) | IF 2.592, ranking: 105/261 (2012)
|
34 |
Wu CM, Lin KW, Teng CH, Huang AM, Chen YC, Yen MH, Wu WB, Pu YS, Lin CN*. 2014. Chalcone derivatives inhibit human platelet aggregation and inhibit growth in human bladder cancer cells. (pdf) | Biol Pharm Bull. 2014. 37(7):1191-8. | IF 1.849, ranking: 163/261 (2012) |
| 35 | Yeh HC, Huang CN, Li CC, Chang LL, Lin HH, Ke HL, Huang AM, Liang PI, Li CF*, Wu WJ*. Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer. (pdf) | World J Urol. 2016. 34(6):835-46. | IF 2.666, ranking: 23/78 (2013) |
| 36 | Lin KW, Maitraie D, Huang AM, Wang JP, Lin CN*. Triterpenoids and an alkamide from Ganoderma tsugae. (pdf) | Fitoterapia. 2016. 108:73-80. | IF 2.345, ranking: 130/255 (2013) |
| 37 | Lin, SR, Yeh, HC, Wang, WJ, Ke, HL, Lin, HH, Hsu, WC, Chao, SY, Hour, TC, Wu, WJ, Pu, YS and Huang, AM*. MiR-193b Mediates CEBPD-induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells. (pdf) | J Cell Biochem. 2017. 118(6):1563-1573. | IF 3.446, ranking 101/289 (2015) |
| 38 | Huang, AM, Lin, KW, Lin, WH, Wu, LH, Chang, HC, Ni, C, Wang, DL, Hsu, HY, Su, CL, Shih, C. 1-Hydroxy-3-[(E)-4-(piperazine-diium)but-2-enyloxy]-9,10-anthraquinone ditrifluoroactate induced autophagic cell death in human PC3 cells. (pdf) | Chem Biol Interac. 2018. 281:60-68. | IF 3.296 (2018) |
| 39 | Hsu, WC, Lee, YC, Liang, PI, Chang, LL, Huang, AM, Lin, HH, Wu, WJ, Li, CC, Li, WM, Jhan, JH, and Ke, HL. CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas. (link) | Disease Markers. 2019. 2019: 2724948. | IF 2.761 (2019) |
| 40 | Hsu, WC, Li, WM, Lee, YC, Huang, AM, Chang, LL, Lin, HH, Wu, WJ, Li, CC, Liang, PI, Ke, HL. MicroRNA-145 Suppresses Cell Migration and Invasion in Upper Tract Urothelial Carcinoma by Targeting ARF6. (link) | FASEB J. 2020. 34(4):5975-5992. | IF 5.3911 (2019) |
| 41 | Lim, LM, Kung, LF, Kuo, MC, Huang, AM, and Kuo, HT*. Timing of mTORI usage and outcomes in kidney transplant recipients. (link) | Int J Med Sci 2021. 18(5):1179-1184 | IF 2.523 (2019) |
| 42 | Wu, YU, Lee, YC, L, WM, Hsu, WC, Lin, HH, Chang, LL, Huang, AM, Jhan, JH, Wu, WJ, Li, CC, Lee, HY, Yeh, HC and Ke, HL*.High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma. (link) | Pathol Int. 2021. 71(7):463-470. | IF 2.534 (2020) |
| 43 | Chien, TM, Lee, HY, Singla, N, Margulis, V, Lotan, Y, Woldu, SL, Huang, CN, Li, CC, Ke, HL, Li, WM, Li, CY, Huang, AM, Yang, SF, Tu, HP, Wu, WJ, and Yeh, HC.*.Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study. (link) | Cancers. 2021. 13(23):5935. | IF 6.639 (2021) |
| 44 | Jhan, JH, Hsu, WC, Lee, YC, Li, WM, Huang, AM, Lin, HH, Wang, CS, Wu, YR, Li, CC, Wu, WJ and Ke, HL*. MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1.(link) | Cancers. 2022. |
IF 6.639 (2021) |
| 45 | Ke, HL, Lee, YC, Li, WM, Wang, CS, Hsu, WC, Lin, HH, Lee, YA, Jhan, JH, Li, CC, Yeh, HC, Wu, WJ and Huang, AM*. High Ubiquitin-Specific Protease 2a Expression Level Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma.(link) | Applied Immunohistochemistry & Molecular Morphology. 2022. 30(4):304-310 | IF 2.085 (2021) |
| 46 | Yuan, CH, Hsu, WC, Huang, AM, Yuan, BC, Chen, IH, Hsu, CA, Chen, RF, Chu, YM, Lin, HH and Ke, HL*. MicroRNA-145-5p modulates Kruppel-like factor 5 and inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma. (link) | BMC Molecular and Cell Biology. 2022. 23(1):28. | IF 2.813 (2022) |
| 47 | Lim, LM, Chung, WY, Hwang , DY, Yu , CC, Ke, HL, Liang, PI, Lin, TW, Cheng, SM, Huang, AM*, and Kuo, HT*. Whole-Exome Sequencing Identified Mutational Profiles of Urothelial Carcinoma post Kidney Transplantation. (link) | Journal of Translational Medicine. 2022. 20(1):324. | IF 8.459 (2022) |
| 48 | Jhan, JH, Ke, HL, Lian, PI, Hsu, WC, Lee, YC, Lin, HH, Wu, YR, Huang, AM, Lee, HY, Yeh , HC, Wu, WJ, Li, CC, Li, WM*. High MRE11 Expression Level Predicts Poor Survival in Upper Tract Urothelial Carcinomas. (link) | Applied Immunohistochemistry & Molecular Morphology. 2023. 31(2):94-100. | IF 1.992 (2022) |
100, Shih-Chuan 1st Road, Kaohsiung, 80708, Taiwan
Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University
Medical Research Building, Rm416
Updated on March 6, 2023
All Rights Reserved!